Form 8-K - Current report:
SEC Accession No. 0001193125-20-226962
Filing Date
2020-08-21
Accepted
2020-08-21 16:01:52
Documents
1
Period of Report
2020-08-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d29503d8k.htm 8-K 19729
  Complete submission text file 0001193125-20-226962.txt   20963
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38938 | Film No.: 201123431
SIC: 2834 Pharmaceutical Preparations